CARA Summary

  2. >
  3. CARA
Ticker CARA
CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.
Exchange NASDAQ
Type Stock
Sector Healthcare
Employees 67
Next Earnings Date July 30th, 2020
IV 75.253131%
IV Percentile 72nd
IV Rank 20.40%
IV Skew 0.022115
IV Skew Percentile 26th
IV Skew Sentiment Bullish
Volume 387,719
Price $15.715
Previous Close $15.68
52-Week High $27.55
52-Week Low $8.88
50-Day Moving Avg. $14.48
200-Day Moving Avg. $17.66
10-Day Avg. Volume 479,339
20-Day Avg. Volume 594,271
30-Day Avg. Volume 606,096
3-Month Avg. Volume 548,469
EPS -$2.55
Outstanding Shares 46,796,000
Float 42,423,940
Market Capitalization $742,653,500
Currency USD
Updated June 2nd, 2020